CLBT
Cellebrite Di Stock Analysis
AI Rating
- Quality6/10
- Growth↑ 8/10
- Value↓ 1/10
CLBT Growth
- Revenue Y/Y↑ 13.70%
- EPS Y/Y↑ 131.46%
- FCF Y/Y↑ 20.58%
CLBT Profitability
- Gross margin ↑ 83.90%
- EPS margin↑ 14.50%
- ROIC 5Y↑ 30.22%
CLBT Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↓ 2.9
Cellebrite Di stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.